LLMpediaThe first transparent, open encyclopedia generated by LLMs

Journal of Clinical Psychiatry

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Menninger Clinic Hop 6
Expansion Funnel Raw 83 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted83
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Journal of Clinical Psychiatry
TitleJournal of Clinical Psychiatry
DisciplinePsychiatry
AbbreviationJ. Clin. Psychiatry
PublisherPhysicians Postgraduate Press
CountryUnited States
FrequencyMonthly
History1960–present
Impact7.2
Impact-year2024

Journal of Clinical Psychiatry is a monthly peer-reviewed medical journal covering clinical psychiatry, psychopharmacology, psychotherapy, and psychiatric epidemiology. It publishes original research, reviews, case reports, and treatment guidelines that inform clinicians, researchers, and policymakers in psychiatric practice and mental health services. The journal has influenced psychiatric standards alongside other periodicals and institutions in North America, Europe, and Asia.

History

The journal was established in 1960 during a period of expansion in psychiatric research alongside publications such as The Lancet, New England Journal of Medicine, American Journal of Psychiatry, British Journal of Psychiatry, and JAMA. Early editorial leadership included clinicians and academics affiliated with institutions like Massachusetts General Hospital, Johns Hopkins School of Medicine, Columbia University, Stanford University School of Medicine, and UCLA. Over decades the journal paralleled developments documented at conferences such as the American Psychiatric Association annual meeting, the World Psychiatric Association congresses, and symposia held by the National Institute of Mental Health and the National Institutes of Health. The journal’s archives reflect shifts observed in landmark studies associated with figures linked to Austrian Academy of Sciences, Royal Society, Harvard Medical School, and pharmaceutical partnerships involving companies akin to Pfizer, GlaxoSmithKline, and Eli Lilly and Company in the late 20th century.

Scope and Content

The journal’s remit includes randomized controlled trials, meta-analyses, practice guidelines, systematic reviews, and case series related to mood disorders, schizophrenia, anxiety disorders, bipolar disorder, and substance use disorders. Articles often intersect with work produced at institutions such as Mayo Clinic, Cleveland Clinic, Mount Sinai Health System, Karolinska Institutet, University of Oxford, University of Cambridge, and Yale School of Medicine. The journal publishes content relevant to regulatory discussions by agencies like the Food and Drug Administration, European Medicines Agency, and policy debates seen at World Health Organization assemblies. It frequently features commentary linked to awardees from Nobel Prize committees, contributors from research centers such as Salk Institute for Biological Studies and Broad Institute, and collaborative investigations with consortia resembling ENIGMA Consortium, Psychiatric Genomics Consortium, and multicenter trials connected to National Health Service sites.

Editorial and Publication Details

Editorial operations have involved editors, associate editors, and editorial boards drawn from academic departments at University of Pennsylvania Perelman School of Medicine, Northwestern University Feinberg School of Medicine, Duke University School of Medicine, University of Toronto, and Imperial College London. The publisher coordinates peer review, copyediting, and ethical oversight with committees patterned after guidelines from organizations such as Committee on Publication Ethics, International Committee of Medical Journal Editors, and institutional review boards at universities like Brown University, University of Michigan, and University of Chicago. The journal issues supplements, special issues, and continuing medical education materials similar to offerings by New England Journal of Medicine and BMJ Publishing Group.

Abstracting and Indexing

The journal is indexed in major databases and citation services comparable to PubMed, MEDLINE, Scopus, Web of Science, and PsycINFO. Coverage facilitates discoverability alongside entries from repositories like ClinicalTrials.gov, catalogues maintained by the Library of Congress, and indexing in services used by libraries at Princeton University Library, British Library, and Bibliothèque nationale de France. Bibliometric aggregation by entities such as Clarivate Analytics and Elsevier influences citation counts and journal metrics used by faculty at universities including Cornell University, North Carolina State University, and University of California, San Francisco.

Impact and Reception

The journal’s articles have been cited in clinical practice guidelines from professional bodies such as the American Psychiatric Association, Royal College of Psychiatrists, and guideline panels convened by National Institute for Health and Care Excellence. Research findings published in the journal have informed textbooks from publishers like Oxford University Press, Cambridge University Press, and Wolters Kluwer Health and have been referenced in reviews in periodicals like Nature Medicine, Science Translational Medicine, and The British Medical Journal. The journal’s impact factor and alternative metrics are monitored by academics and administrators at institutions such as Rutgers University, University of Washington, and University of Illinois Urbana-Champaign.

Controversies and Criticism

The journal has faced scrutiny similar to controversies involving other medical journals regarding conflicts of interest, industry sponsorship, and disclosure practices involving authors affiliated with corporations similar to Johnson & Johnson, Bristol-Myers Squibb, and AstraZeneca. Debates have arisen concerning the interpretation of clinical trial data, publication bias comparable to discussions connected to The New England Journal of Medicine and reanalysis initiatives led by investigative teams at ProPublica and academic groups at Columbia University Mailman School of Public Health. Criticism has also touched on editorial decisions, peer review transparency, and replication challenges analogous to reproducibility debates hosted by organizations like Center for Open Science, National Academies of Sciences, Engineering, and Medicine, and advocacy groups including Mental Health America.

Category:Psychiatry journals